Phenotypes of complement knockouts

Immunopharmacology

Volumn 49, Issue 1-2, 2000, Pages 125-131

  Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Deficiency state; Receptor; Regulatory protein

Indexed keywords

REGULATOR PROTEIN;

COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONFERENCE PAPER; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR FUNCTION; REVIEW;

EID: 0033938511     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)80298-2     Document Type: Conference Paper

References (44)

1. Ahearn J.M., Fischer M.B., Croix D.A., et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:1996;251-262.
2. Arnett F.C. Genetic aspects of human lupus. Clin. Immunol. Immunopathol. 63:1992;4-6.
3. Atkinson J.P. Complement deficiency: predisposing factor to autoimmune syndromes. Clin. Exp. Rheum. 7:(S-3):1989;95-101.
4. Bickerstaff M.C., Botto M., Hutchinson W.L., et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:1999;694-697.
5. Botto M., Dell'Agnola C., Bygrave A.E., et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59.
6. Bowness P., Davies K.A., Norsworthy P.J., et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q. J. Med. 87:1994;455-464.
7. Circolo A., Garnier G., Fukuda W., et al. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic C3 mRNA. Immunopharmacology. 42:1999;135-149.
8. Da Costa X.J., Brockman M.A., Alicot E., et al. Humoral response to herpes simplex virus is complement dependent. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12708-12712.
9. Dalmasso A.P. Complement in the pathophysiology and diagnosis of human diseases. CRC Crit. Rev. Clin. Lab. Sci. 24:1986;123-183.
10. Davoust N., Nataf S., Reiman R., Holers V.M., Campbell I.D., Barnum S.R. Central nervous system-targeted expression of the complement inhibitors Crry prevents experimental allergic encephalomyelitis. J. Immunol. 163:1999;6551-6556.
11. Fang Y., Xu C., Fu Y.-X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:1998;5273-5279.
12. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:1995;127-149.
13. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:1991;359-395.
14. Fischer M.B., Ma M., Goerg S., et al. Regulation of the B cell response to T-dependent antigens by classical pathway of complement. J. Immunol. 157:1996;549-556.
15. Fischer M.B., Prodeus A., Nicholson-Weller A., et al. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159:1997;976-982.
16. Fischer M.B., Ma M., Hsu N.C., Carroll M.C. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3 deficient mice. J. Immunol. 160:1998a;2619-2625.
17. Fischer M.B., Goerg S., Shen L., Prodeus A.P., Goodnow C.C., Kelsoe G., Carroll M.C. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science. 280:1998b;582-585.
18. Gewurz H., Zhang X.-H., Lint T.F. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:1996;54-64.
19. Hopken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature. 383:1996;86-88.
20. Hopken U.E., Lu B., Gerard N.P., Gerard C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 185:1997;749-756.
21. Kim Y.U., Kinoshita T., Molina H., et al. Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:1995;151-159.
22. Kinoshita T., Thyphronitis G., Tsokos G.C., et al. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:1990;651-659.
23. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. J. Immunol. 158:1997;4525-4528.
24. Kozono Y., Abe R., Kozono H., Kelly R.G., Azuma T., Holers V.M. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1998;1565-1572.
25. Kurtz C.B., O'Toole E., Christensen S.M., Weis J.H. The murine complement receptor gene family: IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:1990;3581-3591.
26. Matsumoto M., Fukuda W., Circolo A., et al. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8720-8725.
27. Mitchell D.A., Taylor P.R., Cook H.T., et al. C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162:1999;5676-5679.
28. Molina H., Kinoshita T., Inoue K., Carel J.-C., Holers V.M. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145:1990;2974-2983.
29. Molina H., Wong W., Kinoshita T., Brenner C., Foley S., Holers V.M. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologs of human CR1. J. Exp. Med. 175:1992;121-129.
30. Molina H., Holers V.M., Li B., et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3357-3361.
31. Prodeus A., Goerg S., Shen L.-M., et al. A critical role for complement in maintenance of self-tolerance. Immunity. 9:1999;721-731.
32. Quigg R.J., Lim A., Haas M., Alexander J.J., He C., Carroll M.C. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 53:1998a;320-330.
33. Quigg R.J., He C., Lim A., et al. Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury. J. Exp. Med. 188:1998b;1321-1331.
34. Quigg R.J., Kozono Y., Berthiaume D., et al. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160:1998c;4553-4560.
35. Spicer A.P., Seldin M.F., Gendler S.J. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. J. Immunol. 155:1995;3079-3091.
36. Sun X., Funk C.D., Deng C., Sahu A., Lambris J.D., Song W.C. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Nat. Acad. Sci. U. S. A. 92:1999;628-633.
37. Taylor P.R., Nash J.T., Theodoridis E., Bygrave A.E., Walport M.J., Botto M. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2 and D17H6S45. J. Biol. Chem. 273:1998;1699-1704.
38. Tedder T.F., Zhou L.-J., Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today. 15:1994;437-442.
39. Walport M.J., Lachmann P.J. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum. 31:1988;153-158.
40. Watanabe H., Garnier G., Circolo A., et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor. B.J. Immunol. 164:2000;786-794.
41. Wessels M.R., Butko P., Ma M., Warren H., Lage A., Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U. S. A. 92:1995;11490-11494.
42. Wetsel R.A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7:1995;48-53.
43. Wilson J.G., Ratnoff W.D., Schur P.H., Fearon D.T. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29:1986;739-747.
44. Xu C., Mao D., Holers V.M., Balanca B., Cheng A.M., Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science. 287:2000;498-501.